AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (May 23, 2007). doi:10.1152/ajpregu.00801.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/2/R784    most recent
00801.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faggian, J.
Right arrow Articles by Hooper, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faggian, J.
Right arrow Articles by Hooper, S. B.
Submitted on November 14, 2006
Accepted on May 16, 2007

Changes in versican and chondroitin sulphate proteoglycans during structural development of the lung

Jessica Faggian1, Amanda J Fosang2, Malgorzata Zieba3, Megan J Wallace4, and Stuart Brian Hooper5*

1 Pediatrics, University of Melbourne, Melbourne, Victoria, Australia; Arthritis Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Physiology, Monash University, Monash University, Australia
2 Pediatrics, University of Melbourne, Melbourne, Victoria, Australia; Arthritis Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
3 Physiology, Monash University, Melbourne, Victoria, Australia
4 Physiology, Monash University, Monash University, Australia
5 Physiology, Monash University, Monash University, Victoria, Australia

* To whom correspondence should be addressed. E-mail: stuart.hooper{at}med.monash.edu.au.

We have examined whether changes in versican levels, or in the sulphation pattern of its chondroitin sulphate (CS) side chains, are associated with the reduction in peri-alveolar tissue volumes that characterise lung maturation in late gestation fetal sheep. Lung tissue was collected from fetuses (90-142 days GA) and lambs (2 weeks after term birth). The level and distribution of versican and CS glycosaminoglycans (GAG) was determined using immunohistochemistry whereas fluorophore assisted carbohydrate electrophoresis (FACE) was used to determine changes in CS sulphation patterns. Versican was the predominant CS-containing proteoglycan in the lung and decreased from 19.9±2.7 arbitrary units (au) at 90d GA to 6.0±0.5 au at 142d GA in close association (p<0.05) with the reduction in tissue volumes (from 66.0±4.6% to 25.3±1.5% at 142d); similar reductions occurred for both C-6-S and C-4-S CS side chains. Hyaluronic acid (HA) levels decreased from 1397±258.8 pmol/µg GAG at 90d GA to 92.9±9.9 pmol/µg GAG at 142d GA and the predominant sulfated disaccharide changed from {Delta}-di-6S at 90d GA to {Delta}-di-4S at term. These data indicate that structural development of the lung is closely associated with marked changes in versican levels and the microstructure of CS side chains in peri-saccular/alveolar lung tissue.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.